Latest Governance News

Patronus Resources Limited reported a significant boost in cash reserves to $7.1 million for Q3 2025, driven by strong investing activity despite ongoing operating cash outflows.

Earth’s Energy Limited has halted further exploration spending on its South Australian and Queensland geothermal assets following an independent review, shifting focus to new project opportunities. The company maintains a healthy cash position while managing its existing licences conservatively.

Tyranna Resources has acquired a controlling interest in the expansive Chinguar Gold Project in Angola, positioning itself to explore a region rich in artisanal gold workings with promising geological data.

Air New Zealand has revised its first half 2026 financial outlook to a pre-tax loss between NZD 30 million and 55 million, citing weaker revenue growth and rising costs. The airline is pushing cost-saving measures while highlighting uncertainties ahead.

Sarama Resources has completed the third tranche of its A$2.7 million equity placement, raising A$100,000 to advance exploration at its Cosmo Gold Project and support ongoing arbitration efforts.

Weebit Nano has reported a record quarter with A$7.3 million in customer receipts, securing three key product agreements and progressing critical technology milestones at leading semiconductor fabs.

Sultan Resources has increased its capital raising to $1.1 million through additional investor interest, with key approvals pending at the upcoming AGM. The funds aim to accelerate exploration at its promising projects in Namibia and Western Australia.

Besra Gold has disclosed a significant reduction in its Mineral Resource Estimate to 2.28 million ounces, addressing ASX concerns over recent unusual trading activity. Despite the downgrade, the company’s share price has risen sharply, leaving investors questioning the market dynamics.

Region Group delivered solid financial results for FY25 with modest growth in funds from operations and assets under management, while announcing a planned CEO retirement and maintaining positive guidance for FY26.

Nyrada has completed its Phase I trial for Xolatryp, confirming safety and predictable pharmacokinetics, while securing AU$8.25 million to fund an upcoming Phase IIa trial targeting heart attack patients.

SIV Capital Limited reported a $110,000 net cash outflow for Q1 FY26, maintaining a strong cash reserve of $8.07 million despite its securities suspension by ASX since December 2024.

Cauldron Energy’s recent passive seismic survey at the Yanrey Uranium Project has delineated extensive palaeochannel systems and sharpened high-priority drill targets, setting the stage for a focused exploration campaign.